Germany, July 17 -- Germany based AbbVie Deutschland GmbH & Co. KG has secured contract from AOK PLUS - Die Gesundheitskasse fur Sachsen und Thuringen for Pharmaceutical products - Agreement according to Section 130c SGB V for the drug Maviret with the active ingredient combination Glecaprevir/Pibrentasvir . The value of the contract is not disclosed .
Published by HT Digital Content Services with permission from Pivotal Sources....